MITOS Medical Technologies A.S.

Mitos Medical is a pioneering company in the medical diagnostics field, with a primary focus on advancing the early detection and screening of breast cancer through its innovative product, S.A.F.E. (Scan and Find Early, Microwave Breast Cancer Screening and Diagnosis System). Utilizing advanced microwave imaging technology, S.A.F.E. offers non-invasive, non-radiative screenings, with a remarkable capability to discern minute breast tissue irregularities as small as 3mm. This capacity enables prompt intervention and enhances the likelihood of successful treatment. The innovation behind S.A.F.E. lies in its use of harmless electromagnetic waves for breast cancer screening and early detection, eliminating the need for X-rays and allowing for repeated imaging without causing harm to organic tissue. These features, combined with a pain-free and non-compressive scanning process, enable the detection of tumors close to the thoracic wall, which are often missed by traditional methods. Founded in 2012 and headquartered in Turkey, Mitos Medical operates in various industries including Consumer Electronics, Deep Tech, Digital Health, Hardware, Health Care, Health and Wellness, and Healthtech. Despite the absence of specific details on the last investment, the unique value proposition and potential impact of S.A.F.E. position Mitos Medical as an intriguing prospect for potential investors seeking opportunities in the innovative healthcare technology sector.